Wealth Architects, LLC Eli Lilly & CO Transaction History

Wealth Architects, LLC

$848 Million
Q3 2024

A detailed history of Wealth Architects, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Wealth Architects, LLC holds 1,116 shares of LLY stock, worth $834,779. This represents 0.12% of its overall portfolio holdings.

Number of Shares

1,116

Previous 1,153 3.21%

Holding current value

$834,779

Previous $1.04 Million 5.27%

% of portfolio

0.12%

Previous 0.13%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $28,569 - $35,520	-37 Reduced 3.21%	1,116 $988,000
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $27,833 - $37,237	47 Added 4.25%	1,153 $896,000
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $28,360 - $33,433	-54 Reduced 4.66%	1,106 $644,000
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $24,777 - $34,160	57 Added 5.17%	1,160 $623,000
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $57,872 - $77,381	-165 Reduced 13.01%	1,103 $517,000
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $2,795 - $3,283	9 Added 0.71%	1,268 $435,000
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $15,434 - $17,984	-48 Reduced 3.67%	1,259 $460,000
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $14,527 - $16,555	-49 Reduced 3.61%	1,307 $423,000
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $44,596 - $52,363	-160 Reduced 10.55%	1,356 $440,000
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $938 - $1,166	-4 Reduced 0.26%	1,516 $434,000
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $7,195 - $8,929	32 Added 2.15%	1,520 $420,000
Q3 2021 Nov 09, 2021	BUY	$221.6 - $272.71 $3,988 - $4,908	18 Added 1.22%	1,488 $343,000
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $52,178 - $67,493	289 Added 24.47%	1,470 $337,000
Q1 2021 Apr 29, 2021	BUY	$164.32 - $212.72 $194,061 - $251,222	1,181 New	1,181 $221,000
Q2 2019 Jul 12, 2019	SELL	$110.79 - $129.32 $174,161 - $203,291	-1,572 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$111.31 - $131.02 $174,979 - $205,963	1,572 New	1,572 $204,000
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $234,144 - $262,313	-2,211 Closed	0 $0
Q3 2018 Oct 04, 2018	BUY	$85.86 - $107.31 $189,836 - $237,262	2,211 New	2,211 $237,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.

Account

Wealth Architects, LLC Eli Lilly & CO Transaction History